Prediabetes is a condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as type 2 diabetes (HbA1c 5.7-6.4%). Without intervention, most people with prediabetes develop type 2 diabetes within 5-10 years. This page brings together the three parts of working with prediabetes — metabolic diagnostics, the correction protocol, and the online consultation format — in one place.
Diagnostics are built on a panel of 50+ biomarkers: HbA1c, fasting glucose and insulin, the HOMA-IR insulin resistance index, a lipid panel, hs-CRP, liver and kidney function markers, plus vitamin D and iron status — together these show where a patient sits on the metabolic decline curve, not just the current sugar reading.
The standard workup most patients get elsewhere — fasting glucose or a single HbA1c — does not capture insulin resistance, which typically develops earlier and isn't reliably reflected in either marker alone. That narrower approach can miss prediabetes at a stage when changes are still reversible, and it leaves no baseline data to track whether an intervention is working.